Antibody persistence upto 5 years after primary immunization and booster with an inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children-Reference-Cited by-同舟云学术

Antibody persistence upto 5 years after primary immunization and booster with an inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children

Published:2022-01-31 Issue:1 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Hattasingh Weerawan¹,Chanthavanich Pornthep¹,Sirivichayakul Chukiat¹,Arunsodsai Watcharee¹,Surangsrirat Surachai²,Srisuwannaporn Termsang²,Kaewma Benjawan²,Yoksan Sutee³,Limkittikul Kriengsak¹,Yang Junwei⁴^ORCID,Mao Yu⁴^ORCID

Affiliation:

1. Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

2. Nopparat Rajathanee Hospital, Ministry of Public Health, Bangkok, Thailand

3. Japanese Encephalitis/Dengue Virology Laboratory, Center for Vaccine Development, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Thailand

4. Liaoning Cheng Da Biotechnology Co., Ltd., Shenyang, China

Funder

Liaoning Cheng Da Biotechnology Co., Ltd

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2028513

Reference22 articles.

1. Japanese encephalitis: the vectors, ecology and potential for expansion

2. Meta-Analyses of Japanese Encephalitis Virus Infection, Dissemination, and Transmission Rates in Vectors

3. First indigenous transmission of Japanese Encephalitis in urban areas of National Capital Territory of Delhi, India

4. Viral Etiology of Acute Childhood Encephalitis in Beijing Diagnosed by Analysis of Single Samples

5. Estimated global incidence of Japanese encephalitis: